When is informed consent required in cluster randomized trials in health research?

This article is part of a series of papers examining ethical issues in cluster randomized trials (CRTs) in health research. In the introductory paper in this series, we set out six areas of inquiry that must be addressed if the cluster trial is to be set on a firm ethical foundation. This paper addr...

Full description

Bibliographic Details
Main Authors: McRae, A, Weijer, C, Binik, A, Grimshaw, J, Boruch, R, Brehaut, J, Donner, A, Eccles, M, Saginur, R, White, A, Taljaard, M
Format: Journal article
Language:English
Published: 2011
_version_ 1826290557143482368
author McRae, A
Weijer, C
Binik, A
Grimshaw, J
Boruch, R
Brehaut, J
Donner, A
Eccles, M
Saginur, R
White, A
Taljaard, M
author_facet McRae, A
Weijer, C
Binik, A
Grimshaw, J
Boruch, R
Brehaut, J
Donner, A
Eccles, M
Saginur, R
White, A
Taljaard, M
author_sort McRae, A
collection OXFORD
description This article is part of a series of papers examining ethical issues in cluster randomized trials (CRTs) in health research. In the introductory paper in this series, we set out six areas of inquiry that must be addressed if the cluster trial is to be set on a firm ethical foundation. This paper addresses the second of the questions posed, namely, from whom, when, and how must informed consent be obtained in CRTs in health research? The ethical principle of respect for persons implies that researchers are generally obligated to obtain the informed consent of research subjects. Aspects of CRT design, including cluster randomization, cluster level interventions, and cluster size, present challenges to obtaining informed consent. Here we address five questions related to consent and CRTs: How can a study proceed if informed consent is not possible? Is consent to randomization always required? What information must be disclosed to potential subjects if their cluster has already been randomized? Is passive consent a valid substitute for informed consent? Do health professionals have a moral obligation to participate as subjects in CRTs designed to improve professional practice?We set out a framework based on the moral foundations of informed consent and international regulatory provisions to address each of these questions. First, when informed consent is not possible, a study may proceed if a research ethics committee is satisfied that conditions for a waiver of consent are satisfied. Second, informed consent to randomization may not be required if it is not possible to approach subjects at the time of randomization. Third, when potential subjects are approached after cluster randomization, they must be provided with a detailed description of the interventions in the trial arm to which their cluster has been randomized; detailed information on interventions in other trial arms need not be provided. Fourth, while passive consent may serve a variety of practical ends, it is not a substitute for valid informed consent. Fifth, while health professionals may have a moral obligation to participate as subjects in research, this does not diminish the necessity of informed consent to study participation.
first_indexed 2024-03-07T02:46:00Z
format Journal article
id oxford-uuid:ac19c23d-f6cd-48cf-89e0-768d9f3e0526
institution University of Oxford
language English
last_indexed 2024-03-07T02:46:00Z
publishDate 2011
record_format dspace
spelling oxford-uuid:ac19c23d-f6cd-48cf-89e0-768d9f3e05262022-03-27T03:26:19ZWhen is informed consent required in cluster randomized trials in health research?Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ac19c23d-f6cd-48cf-89e0-768d9f3e0526EnglishSymplectic Elements at Oxford2011McRae, AWeijer, CBinik, AGrimshaw, JBoruch, RBrehaut, JDonner, AEccles, MSaginur, RWhite, ATaljaard, MThis article is part of a series of papers examining ethical issues in cluster randomized trials (CRTs) in health research. In the introductory paper in this series, we set out six areas of inquiry that must be addressed if the cluster trial is to be set on a firm ethical foundation. This paper addresses the second of the questions posed, namely, from whom, when, and how must informed consent be obtained in CRTs in health research? The ethical principle of respect for persons implies that researchers are generally obligated to obtain the informed consent of research subjects. Aspects of CRT design, including cluster randomization, cluster level interventions, and cluster size, present challenges to obtaining informed consent. Here we address five questions related to consent and CRTs: How can a study proceed if informed consent is not possible? Is consent to randomization always required? What information must be disclosed to potential subjects if their cluster has already been randomized? Is passive consent a valid substitute for informed consent? Do health professionals have a moral obligation to participate as subjects in CRTs designed to improve professional practice?We set out a framework based on the moral foundations of informed consent and international regulatory provisions to address each of these questions. First, when informed consent is not possible, a study may proceed if a research ethics committee is satisfied that conditions for a waiver of consent are satisfied. Second, informed consent to randomization may not be required if it is not possible to approach subjects at the time of randomization. Third, when potential subjects are approached after cluster randomization, they must be provided with a detailed description of the interventions in the trial arm to which their cluster has been randomized; detailed information on interventions in other trial arms need not be provided. Fourth, while passive consent may serve a variety of practical ends, it is not a substitute for valid informed consent. Fifth, while health professionals may have a moral obligation to participate as subjects in research, this does not diminish the necessity of informed consent to study participation.
spellingShingle McRae, A
Weijer, C
Binik, A
Grimshaw, J
Boruch, R
Brehaut, J
Donner, A
Eccles, M
Saginur, R
White, A
Taljaard, M
When is informed consent required in cluster randomized trials in health research?
title When is informed consent required in cluster randomized trials in health research?
title_full When is informed consent required in cluster randomized trials in health research?
title_fullStr When is informed consent required in cluster randomized trials in health research?
title_full_unstemmed When is informed consent required in cluster randomized trials in health research?
title_short When is informed consent required in cluster randomized trials in health research?
title_sort when is informed consent required in cluster randomized trials in health research
work_keys_str_mv AT mcraea whenisinformedconsentrequiredinclusterrandomizedtrialsinhealthresearch
AT weijerc whenisinformedconsentrequiredinclusterrandomizedtrialsinhealthresearch
AT binika whenisinformedconsentrequiredinclusterrandomizedtrialsinhealthresearch
AT grimshawj whenisinformedconsentrequiredinclusterrandomizedtrialsinhealthresearch
AT boruchr whenisinformedconsentrequiredinclusterrandomizedtrialsinhealthresearch
AT brehautj whenisinformedconsentrequiredinclusterrandomizedtrialsinhealthresearch
AT donnera whenisinformedconsentrequiredinclusterrandomizedtrialsinhealthresearch
AT ecclesm whenisinformedconsentrequiredinclusterrandomizedtrialsinhealthresearch
AT saginurr whenisinformedconsentrequiredinclusterrandomizedtrialsinhealthresearch
AT whitea whenisinformedconsentrequiredinclusterrandomizedtrialsinhealthresearch
AT taljaardm whenisinformedconsentrequiredinclusterrandomizedtrialsinhealthresearch